Search the Newsreel

Neogen (NEOG) to Release Q4 2026 Financial Results on July 30

Neogen Corporation (NEOG) is set to release its Q4 and full fiscal year 2026 financial results on July 30, with analysts projecting revenues between $150M-$155M for Q4 and around $590M for the full year. GuruFocus assesses NEOG as 16.8% undervalued with a GF Value …

Neogen executives will discuss fiscal 2026 results July 30

Neogen Corporation (NASDAQ: NEOG) announced that it will release its fourth-quarter fiscal year 2026 earnings before the market opens on Thursday, July 30, 2026. Company executives will host a webcast and conference call at 8:00 a.m. Eastern time on the same day to provide …

(NEO) Volatility Zones as Tactical Triggers

This article analyzes Neogenomics Inc. (NYSE: NEO) using AI models, highlighting strong sentiment across all horizons supporting an overweight bias. It outlines three distinct institutional trading strategies—Position Trading, Momentum Breakout, and Risk Hedging—with specific entry, target, and stop-loss levels. The analysis also provides multi-timeframe …

Neogen Chemicals Schedules Q1 Earnings Call On July 27 At 4 PM

Neogen Chemicals to Discuss Q1FY27 Results on July 27 at 4 PM IST

498,424 Shares in Neogen Corporation $NEOG Purchased by Roubaix Capital LLC

Roubaix Capital LLC has acquired a new position in Neogen Corporation (NASDAQ: NEOG) during the first quarter, purchasing 498,424 shares valued at approximately $4.63 million. This stake represents about 0.23% of Neogen's shares and 2.2% of Roubaix's portfolio, contributing to the high institutional ownership …

NeoGenomics (NEO) Stock Looks Above Fair Value After A 134% Run

NeoGenomics (NEO) stock has seen a significant 134.1% return over the past year, but current evaluations suggest it may be overvalued. The company's P/S ratio of 2.6x is significantly higher than the Healthcare industry average of 1.5x, implying the market is pricing in a …

Zoetis' Acquisition of Neogen Genomics Business Faces Regulatory Scrutiny in Australia

The Australian regulatory body, ACCC, is scrutinizing Zoetis' proposed $160 million acquisition of Neogen Genomics business due to significant competition concerns. Both companies are major genomic testing providers for livestock, and the ACCC worries about consolidation and the acquiring firm gaining exclusive access to …

NeoGenomics (NEO) Launches PTEN IHC CDx, Does The Valuation Still Look Full?

NeoGenomics (NEO) has launched a new PTEN IHC CDx diagnostic following FDA approval, contributing to significant recent stock price appreciation. While the company is considered 3.7% undervalued by some metrics, with a fair value estimate of $15.06, its current price-to-sales ratio of 2.5x is …

NGMS stock holds its ground after Neogenomics revenue trends improve

Neogenomics, Inc. (NGMS) reported improved financial results, with 2024 revenue reaching $169.0 million, a 12.5% increase from the previous year, and a significant improvement in adjusted EBITDA from a $25.8 million loss in 2023 to a $3.9 million loss in 2024. This performance, driven …

PRPO vs. NEO: Which Cancer Diagnostics Stock Is the Better Buy?

This article analyzes Precipio, Inc. (PRPO) and NeoGenomics, Inc. (NEO), two oncology diagnostics companies, to determine which offers a better investment opportunity. While both operate in the cancer diagnostics market, NeoGenomics is presented as the stronger buy due to its broader scale, diversified growth …

A Look Back at Testing & Diagnostics Services Stocks’ Q1 Earnings: NeoGenomics (NASDAQ:NEO) Vs The Rest Of The Pack

Neogen Chemicals Q4FY26 revenue rises 22% to INR 247 crore

Neogen Chemicals' (NSE:NEOGEN) Problems Go Beyond Weak Profit

Neogen Chemicals, Balaji Amines shares soar up to 11%; here's why

Neogen Chemicals Q4 FY26: PAT Surges 182%, Battery Chemicals Expansion Underway

NEOGEN: Revenue and profit rose, margins remained strong, and insurance claims are progressing

NeoGenomics (NEO) Releases Q1 2026 Earnings: Revenue Up 11.1% but EPS Misses

NeoGenomics’s (NASDAQ:NEO) Q1 CY2026: Beats On Revenue

NeoGenomics Earnings: What To Look For From NEO

NeoGenomics (NEO) Q4 2024 Earnings Transcript

A Look Back at Testing & Diagnostics Services Stocks’ Q4 Earnings: NeoGenomics (NASDAQ:NEO) Vs The Rest Of The Pack

NEOGENOMICS ($NEO) Releases Q4 2025 Earnings

NeoGenomics (NEO) Q4 Earnings and Revenues Surpass Estimates

Neogen Chemicals Receives Rs 60 Crore Insurance Payment for Fire Incident at Dahej Facility

Neogen Chemicals Releases Q3 FY26 Results and Hosts Earnings Conference Call

Neogen Chemicals Ltd. Share Price Today - Neogen Chemicals Ltd. Stock Price Live NSE/BSE

Why We're Not Concerned Yet About Neogen Chemicals Limited's (NSE:NEOGEN) 26% Share Price Plunge

Neogen Chemicals Shares Price Fall 9% as Q2 Profit Drops 69%

Neogen Chemicals Reports Q2 Revenue Growth, Faces Regulatory Fine

NEOGENOMICS Earnings Results: $NEO Reports Quarterly Earnings | NEO Stock News

Neogen Chemicals Ltd Share Price Today – Live NSE/BSE